Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors

Trends in Neurosciences

Volumn 24, Issue 4, 2001, Pages 230-237

  Civelli, Olivier ^a   Nothacker, Hans Peter ^b   Saito, Yumiko ^b   Wang, Zhiwei ^b   Lin, Steven H S ^b   Reinscheid, Rainer K ^b  

^a Department of Pharmacology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; NEUROTRANSMITTER;

BRAIN FUNCTION; GENE EXPRESSION; HUMAN; LIGAND BINDING; MOLECULAR CLONING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; IMMEDIATE-EARLY PROTEINS; LIGANDS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHOLIPID; SECOND MESSENGER SYSTEMS;

EID: 0035313899     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01763-X     Document Type: Review

References (74)

1. Sequencing the human genome
2. Cloning the gene and cDNA for mammalian β2-adrenergic receptor and homology with rhodopsin
3. Cloning and expression of a rat D2 dopamine receptor cDNA
4. Selective amplification and cloning of four new members of the G protein-coupled receptor family
5. Novel GPCRs and their endogenous ligands: Expanding the boundaries of physiology and pharmacology
6. Drug discovery: A historical perspective
7. Functional genomics: The search for novel neurotransmitters and neuropeptides
8. 1A receptor
9. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
10. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor
11. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: Its involvement in allodynic response to innocuous stimulus
12. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
13. A prolactin-releasing peptide in the brain
14. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor
15. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
16. Molecular characterization of the melanin-concentrating hormone receptor
17. Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor
18. Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1)
19. Identification of the natural ligand of an orphan G protein-coupled receptor involved in the regulation of vasoconstriction
20. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14)
21. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66
22. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and fear in mice
23. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors
24. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
25. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
26. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum
27. Melanin-concentrating hormone is the cognate ligand for the orphan G protein-coupled receptor SLC-1
28. The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor
29. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
30. Receptor for motilin identified in the human gastrointestinal system
31. Identification of receptors for neuromedin U and its role in feeding
32. Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3
33. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3
34. Identification and functional characterization of a novel subtype of neuromedin U receptor
35. Receptor for the pain modulatory neuropeptides NPFF and NPAF is an orphan G protein-coupled receptor
36. Identification of a novel neuromedin U receptor subtype expressed in the central nervous system
37. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system
38. Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U
39. Identification of a novel neuromedin U receptor subtype expressed in the central nervous system
40. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1
41. Sphingosine 1-phosphate signaling through the G protein-coupled receptor Edg-1
42. Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid
43. Characterization of the human cysteinyl leukotriene CysLT1 receptor
44. Sphingosylphosphorylcholine is a ligand for ovarian cancer G protein-coupled receptor 1
45. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor
46. Characterization of the human leukotriene 2 (CysLT2) receptor
47. Molecular cloning and characterization of a second cysteinyl leukotriene receptor: Discovery of a subtype selective agonist
48. Cloning and characterization of cDNA encoding a novel human leukotriene B4 receptor
49. Molecular cloning and characterization of another leukotriene B4 receptor
50. A novel heptointestinal leukotriene B4 receptor: Cloning and characterization
51. Molecular characterization of novel type of histamine receptor preferentially expressed in leukocytes
52. A G protein-coupled receptor for UDP-glucose
53. New neuropeptides containing carboxy-terminal Rfamide and their receptor in mammals
54. Ghrelin induces adiposity in rodents
55. Moving from the orphanin FQ receptor to an opioid receptor using four point mutations
56. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities
57. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene
58. Primary structure and tissue distribution of the orphanin FQ precursor
59. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat
60. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems
61. Neurons containing hypocretin (orexin) project to multiple neuronal systems
62. Immunocytochemical localization of prolactin-releasing peptide in the rat brain
63. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery
64. Cellular localization of prolactin-releasing peptide messenger RNA in the rat brain
65. Immunohistochemical localization of ORL-1 in the central nervous system of the rat
66. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding
67. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor
68. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
69. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
70. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight
71. Independent feeding and metabolic actions of orexins in mice
72. Hypocretin (orexin) deficiency in human narcolepsy
73. Orexin synthesis and response in the gut
74. Sympathetic and cardiovascular actions of orexins in conscious rats